GO2VENT used non-invasively to save COVID-19 patients
All around the world, clinicians have been using the GO2VENT in innovative ways to discover the best way to improve outcomes with COVID-19 patients. In an ongoing study conducted by Dr. Espejo with the support of VORTRAN, his experiences have led to their facility indicating that early intervention for patients with an alkalotic pH, using the GO2VENT non-invasively, greatly improves the survival outcome of COVID-19 patients.
We would love to share other user experiences to spread the word of how the GO2VENT can be best utilized. To aid in this learning experience, please share your thoughts below so other clinicians can benefit from your findings!
Many thanks to VORTRAN who have provided an additional tool to save a greatest number of lives than our initial objective at the beginning of this pandemic in March 2020 and as today, we continue facing this challenge, but due to this support we have more tools to save lives, thank you.
Dr. Hugo Espejo, Deputy Director of Critical Medicine
